Related Experiment Video

Updated: Jul 10, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Hyperaldosteronism: a commonly occurring underlying feature of essential hypertension and the metabolic syndrome?

Tae-Yon Chun1, J Howard Pratt

  • 1Department of Medicine, Indiana University School of Medicine and the VA Medical Center, Indianapolis, Indiana, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|October 18, 2007
PubMed

Insights

Elevated aldosterone is common in hypertension, especially in African-Americans, and may contribute to insulin resistance and metabolic syndrome. Further consideration of aldosterone is crucial for managing these conditions.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Research

Background:

  • Primary aldosteronism is a significant cause of hypertension.
  • Inappropriately elevated aldosterone secretion occurs in hypertensive patients without classic primary aldosteronism, notably in African-Americans.
  • Aldosterone excess is increasingly linked to insulin resistance and metabolic syndrome.

Purpose of the Study:

  • To highlight the prevalence and implications of elevated aldosterone in hypertension.
  • To emphasize the association between aldosterone excess and metabolic dysfunction.
  • To advocate for greater consideration of aldosterone in clinical management.

Main Methods:

  • Review of existing literature on primary aldosteronism and hypertension.
  • Analysis of studies examining aldosterone levels in diverse hypertensive populations.
  • Correlation of aldosterone excess with metabolic syndrome components.

Main Results:

  • A substantial portion of hypertensive individuals exhibit primary aldosteronism.
  • Elevated aldosterone is observed in hypertensive patients not meeting full primary aldosteronism criteria, particularly African-Americans.
  • Aldosterone excess is frequently associated with insulin resistance and metabolic syndrome.

Conclusions:

  • Aldosterone plays a critical role in both hypertension and metabolic conditions.
  • Increased awareness and assessment of aldosterone are necessary for comprehensive patient care.
  • Managing aldosterone levels may be key in treating hypertension and metabolic disturbances.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...